Recent Updates
Recently added Catalysts
TFX Positive Sentiment

Teleflex Features Innovative Dynetic™-35 Balloon-Expandable Cobalt Chromium Stent System at CIRSE 2026

Key Takeaway: Teleflex Incorporated will present its innovative Dynetic™-35 Balloon-Expandable Cobalt Chromium Stent System at CIRSE 2026 in Copenhagen. This event underscores the company's dedication to advancing healthcare technologies. The stent system is backed by the BIONETIC-TRA study, emphasizing its significance in medical advancements.

Market Sentiment Analysis

POSITIVE FACTORS

  • Teleflex showcases innovative medical technologies.
  • The Dynetic™-35 Stent System represents advanced healthcare solutions.
  • Participation in CIRSE 2026 highlights commitment to innovation.

Full Press Release Details

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it will showcase innovative technologies at CIRSE 2026 in Copenhagen, reinforcing its commitment to advancing innovation for healthcare providers. Among the featured technologies will be the Dynetic™-35 Balloon-Expandable Cobalt Chromium Stent System. This technology is supported by the previously presented BIONETIC-TRA study, an investigator-initiated study with a

Frequently Asked Questions

What is the Dynetic™-35 Stent System?

The Dynetic™-35 Stent System is a balloon-expandable cobalt chromium stent designed for medical applications.

Where will Teleflex showcase its technologies?

Teleflex will showcase its technologies at CIRSE 2026 in Copenhagen.

What study supports the Dynetic™-35 Stent System?

The Dynetic™-35 Stent System is supported by the BIONETIC-TRA study.

What is the focus of Teleflex at CIRSE 2026?

Teleflex focuses on advancing innovation for healthcare providers at CIRSE 2026.

Last updated: Sep 4, 2026